Open company graph database — free web & API
Login

HAMARI Holdings Inc.

HAMARI holdings株式会社ハマリホールディングス株式会社Alias
Ticker
—
Listed market
—
Country
Japan
Employees (consolidated)
401
Related companies
3
§01

Basic information

BASIC
Head office
1-19-40 Minamikita, Suminoe-ku, Osaka City, Osaka Prefecture 559-0034
Chief executive
Kei Takami
Capital
11,000,000 JPY
Employees (non-consolidated)
Employees (consolidated)
401 people
Start date
2023-01-20
End date
§02

Websites

1 DOMAINS
§03

Business

6
Manufacture and sale of pharmaceuticals, chemical drugs, and related raw materialsPurchase and sale of pharmaceuticals, chemical drugs, and related raw materialsImport and export of pharmaceuticals, chemical drugs, and related raw materialsManufacture and sale of food, food additives, feed, feed additives, veterinary drugs, pesticides, fertilizers, cosmetics, and related raw materialsReal estate leasing businessAll ancillary and related business activities
§04

Related companies

3 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Hami International Trade (Shanghai) Co., Ltd.
Group
Hamari Pharmaceutical Nutrition Science Co., Ltd.
Group
Senha Trading (Shanghai) Co., Ltd.
Group
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

28 EVENTS

In July 1947, Mr. Hideo Takami founded the Hamari Chemical Research Institute and began manufacturing saccharin.Sources

In December 1948, Hamari Chemical Co., Ltd. (Hamari Chemical Research Institute) was established, and production of bismuth products such as bismuth nitrate, acrylonitrile, and para-acetaminophen benzaldehyde began.Sources

In 1952, the company changed its name to Hamari Pharmaceutical Industrial Co., Ltd.Sources

In January 1966, President Hideo Takami presented the structure of L-DOPA and challenged industrial production.Sources

Since 1972, L-carnosine has been produced and exported to Europe as a nutritional supplement.Sources

In 1980, a joint study on the anti-ulcer effects of the L-carnosine zinc complex was started with Professor Fujimura of Gifu University Medical School.Sources

In 1987, a material patent for Polaprezinc was filed.Sources

Around 1990, the Hamari PFST Yonezawa Plant (formerly Yonezawa Hamari Pharmaceutical Industrial) was running a large cumulative deficit. To eliminate the deficit, Takami Jiro was transferred. He observed frequent machine breakdowns and halted production for monthly maintenance, but tools were often lost. The first step was to reduce inflated equipment-related costs.Sources

From 1992, a combined 5S and process improvement initiative began. Small groups called "circles" participated daily to build continuous improvement.Sources

In 1994, the generic name "Polaprezinc" was coined, and the new anti-ulcer drug "Promac" containing Polaprezinc as the active ingredient was launched by Zelia New Drug.Sources

Since 1996, the company succeeded in eliminating the red‑flag culture.Sources

In 1997, the company obtained a compliance evaluation during an FDA inspection.Sources

In 2002, the 26th Great Invention Award Ishii Kōan Contribution Award and the 2000 Basic Coordination Engineering Research Society Technical Award were received.Sources

Since 2002, a target deadline has been set. The key to development is a hydrogen‑shift asymmetric hydrogenation of imine derivatives derived from substituted phenylacetone.Sources

Research using the Belokon complex was conducted from 2003 to 2004, but due to issues with its physical properties, selectivity, and patentability, the development was ultimately discontinued after about six months.Sources

In 2005, commercial production of the target drug was achieved.Sources

The first lecture by Professor Soloshonok was held at the Shijima headquarters in May 2009.Sources

The second lecture by Professor Soloshonok was held in March 2010.Sources

From October 2010, the first study abroad program in the United States was realized by HAMARI researchers.Sources

In 2011, we were honored to receive the 61st Industrial Technology Award from the Osaka Institute of Technology Association.Sources

The SOL Project was born in November 2011.Sources

The first patent application for our results was filed in December 2012.Sources

Further patent applications for additional results were filed in May 2013.Sources

The trademark was registered in 2015.Sources

A material patent was obtained in 2018.Sources

In July 2019, an international conference on tailor‑made amino acids was held at Yamagata University.Sources

In August 2019, 10 kg of tailor‑made amino acids were produced using SOL technology.Sources

The Symmetry 2021 Best Paper Award was received.Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑